e8vk

ROCHESTER MEDICAL CORPORATION

/s/ David A. Jonas

David A. Jonas
Chief Financial Officer

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 14, 2005

ROCHESTER MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)


Minnesota	0-18933	41-1613227

(State or other jurisdiction	(Commission file number)	(I.R.S. Employer
of incorporation)		Identification No.)

One Rochester Medical Drive, Stewartville, MN 55976
(Address of principal executive offices)

Registrant’s telephone number, including area code: (507) 533-9600

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

The information disclosed under Item 8.01, “Other Events,” below also is intended to be disclosed under this Item 7.01 and is incorporated herein by reference.

Item 8.01 Other Events.

On October 14 2005, Rochester Medical Corporation (the “Company”) issued a press release announcing it has entered into a Group Purchasing Organization contract with Managed Healthcare Association. The agreement becomes effective November 1, 2005 and covers the Company’s urological and continence care products. A copy of the press release that discusses these matters is filed as Exhibit 99.1 to, and incorporated by reference in, this report.

Item 9.01. Financial Statements and Exhibits.

99.1

Press Release dated October 14, 2005, issued by Rochester Medical Corporation.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: October 14, 2005

EXHIBIT INDEX


Exhibit No.		Description

99.1		Press Release dated October 14, 2005, issued by Rochester Medical Corporation.

Exhibit 99.1


		FOR IMMEDIATE RELEASE October 14, 2005

ROCHESTER MEDICAL CORPORATION ANNOUNCES AGREEMENT WITH
MANAGED HEALTH CARE ASSOCIATES, INC. (MHA)

Stewartville, MN October 14, 2005

Rochester Medical Corporation (NASDAQ: ROCM) today announced the signing of a Group Purchasing Organization contract with MHA (Managed Healthcare Association).

MHA is the largest group purchasing organization in the long term care industry with over 2,000 providers serving more than 1.4 million beds in all 50 states. In addition to its core LTC pharmacy business, MHA also provides traditional Group Purchasing services to home infusion, home health care, acute care, laboratory and alternate care locations.

The agreement which takes effect November 1, 2005 covers Rochester Medical’s urological and continence care products.

MHA executive Richard Levine, Director of Contract Services said, “We are very pleased that the Rochester Medical contract continues our policy of providing our members access to a comprehensive portfolio of products with value beyond price. Rochester Medical has unique technologies and products which we are proud to offer our members.”

Commenting on the news, Rochester Medical’s CEO and President Anthony J. Conway said, “This contract represents a significant milestone for the Company. Rochester Medical’s Products and the Company itself will have greatly increased visibility and access in the marketplace.”

Corporate Vice President Martyn Sholtis commented that, “The agreement with MHA highlights our continued commitment to move our technologies forward in the market. We expect this will lead to increased opportunities and sales.”

The immediately preceding statement contains forward-looking statements that involve risks and uncertainties, including the uncertainty of gaining private label distributors for the hydrophilic intermittent catheters in the marketplace, the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory review and response times, as well as other risk factors listed from time to time in the Company’s SEC reports and filings, including, without limitation, the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K (Part II, I tem 6) for the year ended September 30, 2004.

Rochester Medical Corporation develops, manufactures, and markets latex-free disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical ^® brand and under existing private label arrangements.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.